Microbot Medical Inc.

NasdaqCM:MBOT Stock Report

Market Cap: US$16.6m

Microbot Medical Balance Sheet Health

Financial Health criteria checks 4/6

Microbot Medical has a total shareholder equity of $3.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.2M and $1.4M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$4.34m
EquityUS$3.81m
Total liabilitiesUS$1.40m
Total assetsUS$5.21m

Recent financial health updates

Recent updates

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Dec 30
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Sep 01
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Dec 28
Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical acquires Nitiloop, terms undisclosed

Oct 07

Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Sep 13
Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical confirms GLP trial on track to begin later this month

Sep 02

Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Apr 23
Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier

Jan 06

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

Dec 24
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Aug 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

May 12
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Jan 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Microbot Medical's study of surgical robotic system meets endpoints

Jan 14

Financial Position Analysis

Short Term Liabilities: MBOT's short term assets ($5.0M) exceed its short term liabilities ($1.4M).

Long Term Liabilities: MBOT's short term assets ($5.0M) exceed its long term liabilities ($29.0K).


Debt to Equity History and Analysis

Debt Level: MBOT is debt free.

Reducing Debt: MBOT had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MBOT has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: MBOT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.1% each year


Discover healthy companies